Primary experimental recordPositive observation

PMC12016742::ACT015711

Evidence text

Paper-level observation

we observed a higher percentage of human CD3+ T cells (P = 0.0232) in the TME of animals treated with StCl‐GI_GII + αPD‐1 compared to StCl‐GI_GII (P = 0.0232) (Figure 6d).

textConfidence: medium

Assay observation

Activity

Immunomodulatory

Subtype

Antibacterial

Measure

percent_inhibition

Comparator

Raw observation

P = 0.0232 vs StCl-GI_GII

Normalized measurement

=0.0232

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

Homo sapiens

Assay method

Not reported by source

Sequence

EGSRNQDWL

Standardization

ready simple

Source publication

Off‐The‐Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma

Advanced Materials · 2025

DOI 10.1002/adma.202417348 PMC12016742

Parent mention

Related peptide identities

PEPDIA-PLP-000563

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.